Mesenchymal stem cells (MSC) exhibit tropism for sites of tissue damage as well as the
tumor microenvironment. Many of the same inflammatory mediators that are secreted by …

Tumor behavior is not entirely determined by tumor cells. Studies have demonstrated that a
variety of non-tumor cells in the tumor microenvironment affect tumor behavior; thus, a new …

Tumor progression is a multistep phenomenon in which tumor-associated stromal cells
perform an intricate cross-talk with tumor cells, supplying appropriate signals that may …

Mesenchymal stem cells (MSCs) are non‑hematopoietic, multipotent cells, which are able to
differentiate to bone, adipose and cartilage tissue. MSCs have the characteristic of migration …

Over the past few decades, longevity without disease has become an important topic
worldwide. However, as life expectancy increases, the number of patients with cancer is also …

The interactions between tumor cells and the non-malignant stromal and immune cells that
make up the tumor microenvironment (TME) are critical to the pathophysiology of cancer …

Mesenchymal stromal cells (MSCs) are adult multipotent stem cells residing as pericytes in
various tissues and organs where they can differentiate into specialized cells to replace …

Experimental evidence indicates that mesenchymal stromal cells (MSCs) may regulate
tumor microenvironment (TME). It is conceivable that the interaction with MSC can influence …

Mesenchymal stem cells (MSCs) can exhibit a marked tropism towards site of tumors. Many
studies have reported that tumor progression and metastasis increase by MSCs. In contrast …

Mesenchymal stem cells, also known as mesenchymal stromal cells (MSCs), exist in many
tissues and are known to actively migrate to sites of tissue injury, where they participate in …